Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Affan Shoukat

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
JAMA Network Open|January 11, 2022
Estimating COVID-19 Infections, Hospitalizations, and Deaths Following the US Vaccination Campaigns During the PandemicThomas N Vilches, Seyed M Moghadas, Pratha Sah, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2020
The implications of silent transmission for the control of COVID-19 outbreaksSeyed M Moghadas, Meagan C Fitzpatrick, Pratha Sah, et al.
Scientific Reports|July 21, 2017
Asymptomatic Transmission and the Dynamics of Zika InfectionSeyed M Moghadas, Affan Shoukat, Aquino L Espindola, et al.
Vaccine|February 17, 2024
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) studyAffan Shoukat, Carolyn E Bawden, Gergely Röst, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United StatesSeyed M Moghadas, Affan Shoukat, Carolyn E Bawden, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Cost-Effectiveness of Prefusion F Protein-Based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United StatesSeyed M Moghadas, Affan Shoukat, Carolyn E Bawden, et al.
JAMA Network Open|November 6, 2024
Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young AdultsThomas Shin, Chad R Wells, Affan Shoukat, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Quantifying the potential dominance of immune-evading SARS-CoV-2 variants in the United StatesPratha Sah, Thomas N Vilches, Affan Shoukat, et al.
Eclinicalmedicine|October 8, 2021
Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, CanadaShokoofeh Nourbakhsh, Affan Shoukat, Kevin Zhang, et al.
The Lancet. Infectious Diseases|October 10, 2021
Implications of suboptimal COVID-19 vaccination coverage in Florida and TexasPratha Sah, Seyed M Moghadas, Thomas N Vilches, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
JAMA Network Open|January 11, 2022
Estimating COVID-19 Infections, Hospitalizations, and Deaths Following the US Vaccination Campaigns During the PandemicThomas N Vilches, Seyed M Moghadas, Pratha Sah, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2020
The implications of silent transmission for the control of COVID-19 outbreaksSeyed M Moghadas, Meagan C Fitzpatrick, Pratha Sah, et al.
Scientific Reports|July 21, 2017
Asymptomatic Transmission and the Dynamics of Zika InfectionSeyed M Moghadas, Affan Shoukat, Aquino L Espindola, et al.
Vaccine|February 17, 2024
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) studyAffan Shoukat, Carolyn E Bawden, Gergely Röst, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2023
Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United StatesSeyed M Moghadas, Affan Shoukat, Carolyn E Bawden, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Cost-Effectiveness of Prefusion F Protein-Based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United StatesSeyed M Moghadas, Affan Shoukat, Carolyn E Bawden, et al.
JAMA Network Open|November 6, 2024
Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young AdultsThomas Shin, Chad R Wells, Affan Shoukat, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Quantifying the potential dominance of immune-evading SARS-CoV-2 variants in the United StatesPratha Sah, Thomas N Vilches, Affan Shoukat, et al.
Eclinicalmedicine|October 8, 2021
Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, CanadaShokoofeh Nourbakhsh, Affan Shoukat, Kevin Zhang, et al.
The Lancet. Infectious Diseases|October 10, 2021
Implications of suboptimal COVID-19 vaccination coverage in Florida and TexasPratha Sah, Seyed M Moghadas, Thomas N Vilches, et al.
Pageof 4